Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ALEMBIC ALKEM LABORATORIES/
ALEMBIC
 
P/E (TTM) x 37.5 28.2 133.2% View Chart
P/BV x 6.5 1.0 631.7% View Chart
Dividend Yield % 1.0 2.6 38.5%  

Financials

 ALKEM LABORATORIES   ALEMBIC
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ALEMBIC
Mar-23
ALKEM LABORATORIES/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs3,62587 4,166.9%   
Low Rs2,83556 5,106.3%   
Sales per share (Unadj.) Rs970.15.0 19,576.7%  
Earnings per share (Unadj.) Rs84.23.1 2,681.9%  
Cash flow per share (Unadj.) Rs110.23.4 3,238.8%  
Dividends per share (Unadj.) Rs50.002.20 2,272.7%  
Avg Dividend yield %1.53.1 50.1%  
Book value per share (Unadj.) Rs756.480.9 934.7%  
Shares outstanding (eoy) m119.57256.78 46.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.314.4 23.2%   
Avg P/E ratio x38.422.7 169.0%  
P/CF ratio (eoy) x29.321.0 139.9%  
Price / Book Value ratio x4.30.9 484.9%  
Dividend payout %59.470.1 84.7%   
Avg Mkt Cap Rs m386,20718,298 2,110.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,314240 8,864.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,9931,272 9,115.9%  
Other income Rs m2,161643 336.2%   
Total revenues Rs m118,1531,915 6,169.7%   
Gross profit Rs m15,065297 5,068.2%  
Depreciation Rs m3,10467 4,617.3%   
Interest Rs m1,0745 23,088.2%   
Profit before tax Rs m13,048868 1,503.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,98062 4,822.1%   
Profit after tax Rs m10,068806 1,248.8%  
Gross profit margin %13.023.4 55.6%  
Effective tax rate %22.87.1 320.8%   
Net profit margin %8.763.4 13.7%  
BALANCE SHEET DATA
Current assets Rs m86,0641,721 4,999.8%   
Current liabilities Rs m37,071838 4,423.2%   
Net working cap to sales %42.269.4 60.8%  
Current ratio x2.32.1 113.0%  
Inventory Days Days335,038 0.6%  
Debtors Days Days67673 10.0%  
Net fixed assets Rs m37,24520,324 183.2%   
Share capital Rs m239514 46.6%   
"Free" reserves Rs m90,20820,267 445.1%   
Net worth Rs m90,44720,780 435.3%   
Long term debt Rs m00-   
Total assets Rs m124,54122,046 564.9%  
Interest coverage x13.2187.7 7.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.1 1,613.7%   
Return on assets %8.93.7 243.2%  
Return on equity %11.13.9 286.9%  
Return on capital %15.64.2 371.8%  
Exports to sales %14.61.2 1,183.3%   
Imports to sales %02.4 0.0%   
Exports (fob) Rs m16,91616 107,884.6%   
Imports (cif) Rs mNA30 0.0%   
Fx inflow Rs m16,91616 107,884.6%   
Fx outflow Rs m4,19030 14,011.7%   
Net fx Rs m12,727-14 -89,499.3%   
CASH FLOW
From Operations Rs m16,825389 4,330.4%  
From Investments Rs m1,12873 1,546.6%  
From Financial Activity Rs m-17,608-464 3,795.9%  
Net Cashflow Rs m416-2 -17,341.7%  

Share Holding

Indian Promoters % 56.7 70.9 80.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 0.9 2,595.7%  
FIIs % 8.5 0.9 953.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 29.1 148.6%  
Shareholders   65,184 94,012 69.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs ALEMBIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs ALEMBIC Share Price Performance

Period ALKEM LABORATORIES ALEMBIC S&P BSE HEALTHCARE
1-Day -1.18% 4.34% 1.18%
1-Month -0.99% -14.48% -0.75%
1-Year 52.26% 48.73% 61.82%
3-Year CAGR 21.70% -6.26% 18.16%
5-Year CAGR 22.99% 14.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the ALEMBIC share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of ALEMBIC the stake stands at 70.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of ALEMBIC.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

ALEMBIC paid Rs 2.2, and its dividend payout ratio stood at 70.1%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of ALEMBIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.